Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>In situ</i>rheological monitoring of diffusion-controlled hydrogel crosslinking for embedded 3D bioprinting.

Biofabrication·2026

Same author

Physiological Buffer Selection Alters the Mechanics of Hydrogels with Hydrazone Cross-Links.

Biomacromolecules·2026

Same author

Hydrogel-imposed boundary conditions guide single-lumen neuroepithelial morphogenesis.

bioRxiv : the preprint server for biology·2026

Same author

Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state.

Nature communications·2025

Same author

Polarized Distribution of Lipid Droplets with Long Acyl Chains and Unsaturation are Hallmarks of Human Intestinal Enteroid Differentiation.

Analytical chemistry·2025

Same author

Bioengineering mini-colons for ex vivo colorectal cancer research.

Nature protocols·2025

Search research articles

Related Experiment Video

Updated: Oct 24, 2025

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Next-generation cancer organoids.

Bauer L LeSavage¹, Riley A Suhar², Nicolas Broguiere^3,4

¹Department of Bioengineering, Stanford University, Stanford, CA, USA.

Nature Materials

|August 13, 2021

Summary

This summary is machine-generated.

Patient-specific organoid models capture tumor features but lack standardization. This study addresses challenges and advancements in standardizing cancer organoid culture for reproducible research and personalized medicine.

More Related Videos

Establishment and Culture of Patient-Derived Breast Organoids

Establishment and Culture of Patient-Derived Breast Organoids

Published on: February 17, 2023

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Published on: November 11, 2022

Related Experiment Videos

Last Updated: Oct 24, 2025

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

Establishment and Culture of Patient-Derived Breast Organoids

Establishment and Culture of Patient-Derived Breast Organoids

Published on: February 17, 2023

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Published on: November 11, 2022

Area of Science:

Biomedical research
Cancer biology
Translational medicine

Background:

Organoid models of patient-specific tumors are crucial for understanding cancer heterogeneity and advancing personalized medicine.
Organoids preserve key tumor characteristics (genetic, proteomic, morphological, pharmacotypic) in vitro, enabling manipulation.
Current cancer organoid culture methods suffer from uncontrolled and irreproducible techniques.

Purpose of the Study:

To highlight the challenges in current cancer organoid culture.
To discuss multidisciplinary advancements for standardizing cancer organoid systems.
To identify opportunities for next-generation, reproducible cancer organoid platforms.

Main Methods:

Review of current organoid culture protocols.
Analysis of non-standardized facets (tissue sources, media, matrices).
Identification of multidisciplinary advancements and opportunities.

Main Results:

Cancer organoid culture faces significant variability from tissue processing, media, and matrices.
Standardization is essential to leverage organoids' potential for recapitulating tumor heterogeneity.
Recent advancements offer pathways toward more reproducible cancer organoid systems.

Conclusions:

Standardizing cancer organoid culture is critical for reliable research and clinical translation.
Addressing technical variability will accelerate the use of organoids in personalized cancer care.
Next-generation, standardized organoid systems promise to enhance our understanding and treatment of cancer.